「prog」の検索結果
13件：6～10件目を表示
-
ing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medic...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
研究開発パイプライン | 研究開発活動 | 千寿製薬株式会社
開発進捗状況PROGRESS OF DEVELOPMENT フェーズ1以降の情報を開示しています 開発テーマ対象疾患開発段階（地域） SJP-0132ドライアイ上市（日本） プラノプロフェン抗炎症申請中（ベトナム） SJP-0132ドライアイP3（中国） SJP-0008網膜中心動脈閉塞症P3（日本） SJP-0170緑内障P3（日本） SJP-0154ドライアイP2（日本） SJP-0049アレ...
https://www.senju.co.jp/rd/pipeline.html -
use. About Glaucoma Glaucoma is a disease in which the optic nerve is gradually damaged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
apeutic drug is available, and corneal transplantation is performed in patients with severe disease progression. We will continue to take on the challenge to develop innovative therapeutic drugs that ...
http://www.senju.co.jp/english/rd/policy/ -
use. About Glaucoma Glaucoma is a disease in which the optic nerve is gradually damaged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf